Cancer Research Institute

04/11/2026

“I am just so grateful for all the research that contributed to immunotherapy,” describes Dana, a stage 4 esophageal cancer survivor. “I’m a direct beneficiary of it. Not everyone is as lucky as I am — and it’s incredibly meaningful to be part of something that’s helping so many people.”

Discover how advocacy and immunotherapy changed her life: https://bit.ly/3OdDDcB

Dana Deighton defied a stage 4 esophageal cancer diagnosis, advocating for herself and finding hope through immunotherapy.

04/10/2026

What do experts wish more people knew about colore**al cancer, and what steps can people take to prevent it? "Awareness and early testing are critical," Yale School of Medicine describes. "When detected early, colore**al cancer is often highly treatable, and younger patients frequently experience better survival outcomes than older adults." Read more:

March is National Colore**al Cancer Awareness Month. In this 3 Essential Questions feature, Yale School of Public Health’s Dr. Caroline Johnson and Dr. Sunny

04/09/2026

We are thrilled to share that the American Association for Cancer Research (AACR)- CRI Lloyd J. Old Award in Cancer Immunology will be presented to Dr. Kenneth M. Murphy during the AACR Annual Meeting 2026, to be held April 17-22 in San Diego, California!

“The Lloyd J. Old Award honors scientists whose work doesn’t just advance a field—it reshapes how we understand biology at its core,” says CRI's CEO, Dr. Alicia Zhou. “Dr. Murphy’s discoveries have defined the rules by which dendritic cells orchestrate immune responses, providing a foundation that continues to inform how we design the next generation of cancer immunotherapies.”

Read more: https://bit.ly/4t1SaY9

Kenneth M. Murphy, MD, PhD, was honored with the 2026 AACR-CRI Lloyd J. Old Award for outstanding contributions to cancer immunology and advancing new cancer treatments.

04/08/2026

"Immunotherapy saved my life," emphasizes stage 4 esophageal cancer survivor, Dana. Hear her inspiring story, during April's Esophageal Cancer Awareness Month: https://bit.ly/3OdDDcB

04/07/2026

☀️ 🧴 🔬 How are advances in genetics and genomics reshaping our understanding of skin cancer risk and prevention, and what disparities persist regarding skin cancer screening and access to care? Discover with Targeted Oncology: https://bit.ly/413MX5J

Dr. Maral Kibarian Skelsey discussed how advances in genetics and genomics are reshaping the understanding of skin cancer risk and prevention.

04/05/2026

CRI-funded scientists have been at the forefront of discovering how the immune system can be harnessed to fight multiple myeloma, from identifying new therapeutic targets and improving CAR T-cell therapies, to developing novel detection technologies and exploring how to prevent disease progression.

Today, CRI continues to invest in the next-generation of multiple myeloma immunotherapy research. Explore: https://bit.ly/3QbPKHy

Immunotherapy for Multiple Myeloma Learn how immunotherapy is transforming the treatment of multiple myeloma What Is Multiple Myeloma? Multiple myeloma is the second most common blood cancer worldwide, accounting for approximately 10% [...]

04/04/2026

Facing a stage 4 esophageal cancer diagnosis, Dana refused to accept the limits placed on her care. Fighting with uncertainty and discouraging odds, she pushed for answers when no clear path forward existed. Her persistence led her to an emerging immunotherapy treatment that changed everything. Hear more: https://bit.ly/3OdDDcB

Dana Deighton defied a stage 4 esophageal cancer diagnosis, advocating for herself and finding hope through immunotherapy.

04/03/2026

Congratulations to CRI Scientific Advisory Council Director Dr. James Allison, CRI SAC member Dr. Carl June, 2021 William B. Coley Award recipients and Nobel Prize laureates Dr. Katalin Karikó and Dr. Drew Weissman, and Nobel Prize laureates Dr. Fred Ramsdell and Dr. Jennifer Doudna, who have all been named to Forbes 250: America's Greatest Innovators.

"They aren’t just inventors; they’re business leaders who bring their breakthroughs to market, transforming entire industries and creating new ones." Discover:

The Forbes Innovator 250: America's Greatest Innovators showcases the visionaries shaping our future. Find the full list of great minds and the mark they are leaving on our history.

04/01/2026

At just 26, Mrinali Dhembla was diagnosed with stage 3 re**al cancer that had spread to her spine. Thanks to immunotherapy, she was declared cancer-free after only 4 months of treatment.

"Immunotherapy spared Dhembla from months of debilitating chemotherapy and radiation treatments, and Dhembla even ran a 5K during her treatment period," ABC News describes. Hear more: https://bit.ly/4c2ch11

A 26-year-old is now "cancer-free" after receiving a new treatment for colore**al cancer.

03/31/2026

🫂 1 in 5 people diagnosed with colore**al cancer are under age 55. During March's Colore**al Cancer Awareness Month, discover potential risk factors, and review prevention tips, with NBC Bay Area and CRI:

Medical experts are reminding young adults to be screened early for colore**al cancer due to an increase in cases for people under the age of 55.

03/30/2026

📊 While melanoma and lung cancer have seen dramatic survival gains, many cancers remain resistant to current immunotherapies. The 5 year survival rate for pancreatic cancer remains at just 13%, and uterine corpus cancer mortality has risen for 26 consecutive years.

↪️ Discover what lies ahead for immunotherapy, and explore what can be done to continue to unlock its potential for all patients: https://bit.ly/3OxCNam

03/29/2026

Gordon had exhausted nearly every treatment option to fight stage 4 colore**al cancer. Discover how a second opinion and a new immunotherapy combination changed everything: https://bit.ly/403f3gW

After exhausting nearly every option for stage 4 colore**al cancer, Gordon Levine found new hope in immunotherapy. Today, he's cancer-free and advocating for more patients to get the same second chance.